John Cox Insider Trading $SGTX Sigilon Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for John Cox.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of John Cox. John Cox is Director in REPLIGEN CORP ($RGEN) and EVP Pharmaceutical Oper & Tech in BIOGEN INC. ($IDPH) and Chief Executive Officer in Bioverativ Inc. ($BIVV) and in Sigilon Therapeutics, Inc. ($SGTX) and Director in Sigilon Therapeutics, Inc. ($SGTX).

John Cox in Sigilon Therapeutics, Inc.

Trading Symbol: SGTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John Cox:
Holdings: 4,444 shares
Latest Transaction: Jun 28 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of John Cox in Sigilon Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, IDPH, BIVV, RGEN, SGTX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 28 2021SGTXSigilon Therapeuti ...Cox JohnOption ExerciseA9.978,88888,6138,888
Dec 10 2020SGTXSigilon Therapeuti ...Cox JohnDirectorOption ExerciseC0.004,44400
Dec 10 2020SGTXSigilon Therapeuti ...Cox JohnDirectorBuyC0.004,44404,4440 to 4.4 K

Page:   1